The Cooper Companies, Inc. (NASDAQ:COO) Shares Purchased by Soros Fund Management LLC

Soros Fund Management LLC grew its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 29.1% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 225,930 shares of the medical device company's stock after buying an additional 50,930 shares during the quarter. Soros Fund Management LLC owned 0.11% of Cooper Companies worth $20,770,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Byrne Asset Management LLC purchased a new position in Cooper Companies during the fourth quarter worth approximately $33,000. OFI Invest Asset Management purchased a new stake in Cooper Companies in the 4th quarter worth $34,000. New Age Alpha Advisors LLC acquired a new position in Cooper Companies during the fourth quarter worth $38,000. Covestor Ltd lifted its holdings in Cooper Companies by 35.5% during the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after purchasing an additional 120 shares in the last quarter. Finally, West Financial Advisors LLC acquired a new stake in shares of Cooper Companies in the fourth quarter valued at about $49,000. Institutional investors and hedge funds own 24.39% of the company's stock.

Cooper Companies Trading Up 1.4 %

COO stock traded up $1.16 during midday trading on Friday, hitting $82.30. 1,708,555 shares of the company's stock were exchanged, compared to its average volume of 1,432,746. The Cooper Companies, Inc. has a 1-year low of $69.81 and a 1-year high of $112.38. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $16.46 billion, a PE ratio of 42.21, a P/E/G ratio of 2.25 and a beta of 1.08. The business has a 50-day simple moving average of $81.44 and a two-hundred day simple moving average of $91.79.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. On average, sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the company. BNP Paribas upgraded Cooper Companies to a "hold" rating in a research note on Thursday, March 13th. Piper Sandler reissued an "overweight" rating and issued a $115.00 price objective (down from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Needham & Company LLC reaffirmed a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. Robert W. Baird decreased their price target on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a research note on Friday, March 7th. Finally, Citigroup lowered their price target on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $110.25.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.